 Efficacy intravenous gammaglobulin therapy chronic refractory polymyositis dermatomyositis open study adult patients PURPOSE Polymyositis dermatomyositis inflammatory muscular diseases unknown cause Many interventions available patients conditions corticosteroids immunosuppressive drugs plasmapheresis total body irradiation therapies effective certain serious side effects attempt efficacy polyvalent intravenous immunoglobulin IVIG patients polymyositis dermatomyositis refractory traditional treatment PATIENTS METHODS patients women men mean age SD years chronic refractory polymyositis dermatomyositis high doses IVIG failure traditional treatments prednisone azathioprine cyclosporine chlorambucil plasmapheresis lymphopheresis total body irradiation patient positive results picornavirus serologic testing IVIG first treatment choice IVIG therapy prednisone patients methotrexate patients plasmapheresis patient changes treatment months introduction IVIG therapy increases dose treatment Preparations polyvalent human intravenous gammaglobulins intact immunoglobulin Thirteen patients g/kg days month patients g/kg days month mean duration treatment months RESULTS Clinical assessment measurement proximal muscle power biochemical studies treatment period Significant clinical improvement patients Mean muscle power patients IVIG therapy Eighteen patients biochemical improvement patients normal initial serum creatine kinase levels clinical improvement Mean creatine kinase levels patients IVIG therapy significant decrease first IVIG perfusions Side effects IVIG therapy patients effects mild IVIG therapy steroid doses second third IVIG infusion CONCLUSION IVIG efficacious new therapy polymyositis dermatomyositis role treatment diseases steroid immunosuppressive medications